FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568909840> ?p ?o ?g. }

• W2568909840 endingPage "986" @default.
• W2568909840 startingPage "981" @default.
• W2568909840 abstract "Inclusion body hepatitis (IBH) is one of the major viral infections causing substantial economic loss to the global poultry industry. The disease is characterized by a sudden onset of mortality (2–30%) and high morbidity (60–70%). IBH is caused by a number of serotypes of fowl adenovirus with substantially low levels of serotype cross protection. Thus far, there is no effective and safe vaccine commercially available in the North America for the control of IBH in chickens. Poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) is a high molecular weight, biodegradable water soluble polymer that has been well characterized as a safe and effective adjuvant for a number of experimental veterinary vaccines. Similarly, host defence peptides, including β-defensins, have also been shown to exhibit strong adjuvant potential. In this study, we evaluated the adjuvant activity of PCEP and avian beta defensin (ABD) in a vaccine formulation containing inactivated fowl adenovirus (FAdV) serotype 8b administered in ovo. Our data showed that a combination of PCEP and inactivated virus is capable of inducing a robust and long lasting antibody response. Moreover, significant enhancement of IFN-γ, IFN-α, IL-12(p40) and IL-6 gene expression under the influence of PCEP suggests that as an in ovo adjuvant PCEP has the ability to activate a substantial balanced immune response in chickens. To our knowledge, these are the first studies in which PCEP and ABD have been characterized as adjuvants for the development of an in ovo poultry vaccine. It is expected that these preliminary studies will be helpful in the development of safer and more effective in ovo vaccine against IBH and other infectious diseases affecting chickens." @default.
• W2568909840 created "2017-01-13" @default.
• W2568909840 creator A5006477741 @default.
• W2568909840 creator A5016300240 @default.
• W2568909840 creator A5028351806 @default.
• W2568909840 creator A5035086403 @default.
• W2568909840 creator A5044466824 @default.
• W2568909840 creator A5054537882 @default.
• W2568909840 creator A5058908151 @default.
• W2568909840 date "2017-02-01" @default.
• W2568909840 modified "2023-10-18" @default.
• W2568909840 title "Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens" @default.
• W2568909840 cites W1676309931 @default.
• W2568909840 cites W1815610272 @default.
• W2568909840 cites W1969434760 @default.
• W2568909840 cites W1972571960 @default.
• W2568909840 cites W1991392668 @default.
• W2568909840 cites W2002076761 @default.
• W2568909840 cites W2002563903 @default.
• W2568909840 cites W2008453088 @default.
• W2568909840 cites W2012464349 @default.
• W2568909840 cites W2013197392 @default.
• W2568909840 cites W2026561645 @default.
• W2568909840 cites W2027544080 @default.
• W2568909840 cites W2027752733 @default.
• W2568909840 cites W2036372783 @default.
• W2568909840 cites W2045430045 @default.
• W2568909840 cites W2045855468 @default.
• W2568909840 cites W2046069397 @default.
• W2568909840 cites W2047109541 @default.
• W2568909840 cites W2050965415 @default.
• W2568909840 cites W2057383507 @default.
• W2568909840 cites W2058516438 @default.
• W2568909840 cites W2066327121 @default.
• W2568909840 cites W2069999887 @default.
• W2568909840 cites W2078671799 @default.
• W2568909840 cites W2079514383 @default.
• W2568909840 cites W2088534886 @default.
• W2568909840 cites W2107142381 @default.
• W2568909840 cites W2107277218 @default.
• W2568909840 cites W2108366911 @default.
• W2568909840 cites W2120787532 @default.
• W2568909840 cites W2142713810 @default.
• W2568909840 cites W2142812246 @default.
• W2568909840 cites W2152765064 @default.
• W2568909840 cites W2165731518 @default.
• W2568909840 cites W2166958810 @default.
• W2568909840 cites W2168557628 @default.
• W2568909840 cites W2169257080 @default.
• W2568909840 cites W2175630880 @default.
• W2568909840 cites W2187449711 @default.
• W2568909840 cites W2323815103 @default.
• W2568909840 cites W4317649972 @default.
• W2568909840 cites W4319290844 @default.
• W2568909840 doi "https://doi.org/10.1016/j.vaccine.2016.12.023" @default.
• W2568909840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28087147" @default.
• W2568909840 hasPublicationYear "2017" @default.
• W2568909840 type Work @default.
• W2568909840 sameAs 2568909840 @default.
• W2568909840 citedByCount "19" @default.
• W2568909840 countsByYear W25689098402017 @default.
• W2568909840 countsByYear W25689098402018 @default.
• W2568909840 countsByYear W25689098402019 @default.
• W2568909840 countsByYear W25689098402020 @default.
• W2568909840 countsByYear W25689098402021 @default.
• W2568909840 countsByYear W25689098402022 @default.
• W2568909840 countsByYear W25689098402023 @default.
• W2568909840 crossrefType "journal-article" @default.
• W2568909840 hasAuthorship W2568909840A5006477741 @default.
• W2568909840 hasAuthorship W2568909840A5016300240 @default.
• W2568909840 hasAuthorship W2568909840A5028351806 @default.
• W2568909840 hasAuthorship W2568909840A5035086403 @default.
• W2568909840 hasAuthorship W2568909840A5044466824 @default.
• W2568909840 hasAuthorship W2568909840A5054537882 @default.
• W2568909840 hasAuthorship W2568909840A5058908151 @default.
• W2568909840 hasConcept C159047783 @default.
• W2568909840 hasConcept C159654299 @default.
• W2568909840 hasConcept C196843134 @default.
• W2568909840 hasConcept C203014093 @default.
• W2568909840 hasConcept C22070199 @default.
• W2568909840 hasConcept C2777863537 @default.
• W2568909840 hasConcept C2778765379 @default.
• W2568909840 hasConcept C86803240 @default.
• W2568909840 hasConcept C8891405 @default.
• W2568909840 hasConcept C89423630 @default.
• W2568909840 hasConcept C95444343 @default.
• W2568909840 hasConceptScore W2568909840C159047783 @default.
• W2568909840 hasConceptScore W2568909840C159654299 @default.
• W2568909840 hasConceptScore W2568909840C196843134 @default.
• W2568909840 hasConceptScore W2568909840C203014093 @default.
• W2568909840 hasConceptScore W2568909840C22070199 @default.
• W2568909840 hasConceptScore W2568909840C2777863537 @default.
• W2568909840 hasConceptScore W2568909840C2778765379 @default.
• W2568909840 hasConceptScore W2568909840C86803240 @default.
• W2568909840 hasConceptScore W2568909840C8891405 @default.
• W2568909840 hasConceptScore W2568909840C89423630 @default.
• W2568909840 hasConceptScore W2568909840C95444343 @default.
• W2568909840 hasFunder F4320310866 @default.

• next